A 9-Year Evaluation of Temporal Trends in Alosetron Postmarketing Safety Under the Risk Management Program
Therapeutic Advances in Gastroenterology - United Kingdom
doi 10.1177/1756283x13491798
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 18, 2013
Authors
Publisher
SAGE Publications